# Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza

> **NCT00192413** · PHASE3 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 3009 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Cold-adapted influenza vaccine trivalent (CAIV-T)
- **BIOLOGICAL:** Trivalent Inactivated Vaccine (TIV)

## Key facts

- **NCT ID:** NCT00192413
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2002-11
- **Final completion:** 2002-11
- **Target enrollment:** 3009 (ACTUAL)
- **Last updated:** 2012-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192413, "Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00192413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*